BioPharma Intelligence Hub
FDA catalyst tracker, drug pipeline monitor & clinical trial data for 855 biotech companies. Free data from FDA, SEC EDGAR & ClinicalTrials.gov.
Upcoming Catalysts
| Date | Company | Drug | Event | Grade |
|---|---|---|---|---|
| 2026-07-13 | CNTB | — | Phase2 readout | D |
| 2026-07-13 | INCY | — | Phase3 readout | A+ |
| 2026-07-15 | SXTP | — | Phase2 readout | D |
| 2026-07-15 | PFE | — | Phase1 readout | A+ |
| 2026-07-16 | VRTX | — | Phase1 readout | A+ |
| 2026-07-20 | NAGE | — | Phase2 readout | D |
| 2026-07-21 | SXTC | — | Phase2 readout | D |
| 2026-07-22 | INCY | — | Phase2 readout | A+ |
| 2026-07-23 | N/A | — | Adcom | — |
| 2026-07-23 | BNTX | — | Phase3 readout | D |
BioPharma Companies
| Ticker | Company | Sector | Grade |
|---|---|---|---|
| FDMT | 4D Molecular Therapeutics, Inc. | Biotechnology | D |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | Pharmaceutical | D |
| AARD | Aardvark Therapeutics, Inc. | Pharmaceutical | D |
| ABT | ABBOTT LABORATORIES | Pharmaceutical | A+ |
| ABBV | AbbVie Inc. | Pharmaceutical | A+ |
| ABCL | AbCellera Biologics Inc. | Pharmaceutical | D |
| ABEO | ABEONA THERAPEUTICS INC. | Pharmaceutical | D |
| ABVX | Abivax S.A. | Pharmaceutical | D |
| ABPO | Abpro Holdings, Inc. | Biotechnology | D |
| ABSI | Absci Corp | Biotechnology | D |
What is the BioPharma Intelligence Hub?
A free, data-driven platform that aggregates information from official US government sources to help you track pharmaceutical and biotechnology company developments. All data comes from public domain sources: the U.S. Food & Drug Administration (FDA), the Securities and Exchange Commission (SEC EDGAR), and the National Library of Medicine (ClinicalTrials.gov).
Catalyst Calendar
Track upcoming PDUFA dates, AdCom meetings, Phase 3 readouts, and other FDA regulatory events.
View Calendar →Company Pipelines
Explore drug pipelines for 800+ biotech and pharma companies with trial status and regulatory timelines.
Browse Companies →Clinical Trials
Monitor active clinical trials from ClinicalTrials.gov, organized by company, phase, and indication.
SEC Filings
FDA-related 8-K filings parsed and organized by company. Direct links to SEC EDGAR source documents.
Pipeline Development Grades
Companies are assessed using a transparent, published methodology based on objective data points. Grades reflect pipeline development progress, not investment merit.